What this study is
The goal of this study is to learn methods doctors can use to help improve the cystoscopy experience. Specifically, this study will determine if listening to music, and the amount of time Lidocaine (a numbing medication) is allowed to rest in your urethra before beginning the cystoscopy procedure, will improve the cystoscopy experience.
What's being tested
- Headphones
Intervention · DEVICE
Music playlists include Jazz, New Age, and Classical. Participants randomized to listening to music will chose to listen to one of the three playlists provided. Headphones with a single-use cover will be placed over the ears prior to the administration of numbing medication, and prior to the start of the cystoscopy procedure.
- Dwell time 5-10 minutes
Intervention · DRUG
Numbing medication dwell time, 5-10 minutes.
- Dwell Time more than 10 minutes
Intervention · DRUG
Numbing medication dwell time, >10 minutes.
Study details
- Sponsor
- Florian Schroeck
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer · Hematuria
- Enrolling
- 1,740 people
- Starts
- 2026-11-01
- Est. completion
- 2031-09-01
- Design
- Open-label, randomized, factorial, Phase 3
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Undergoing office-based cystoscopy for bladder cancer diagnosis, surveillance, or evaluation of anatomic abnormalities.
You can't join if
- Allergy to or intolerance of lidocaine.
- Intolerance of all offered music genre playlists (Jazz, Classical, New Age), such that no acceptable music option exists.
- Known pregnancy or lactation (routine pregnancy testing is not required)
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (5)
5 openUniversity of Alabama at Birmingham
Birmingham, Alabama, United States
- Kaelin Hodges · Contactkaelins@uab.edu
- Charles Peyton, MD · Principal investigator
University of North Carolina
Chapel Hill, North Carolina, United States
- Deborah Usinger · Contactdusinger@email.unc.edu
- Angela B Smith, MD, MS · Principal investigator
Novant Health New Hanover Regional Medical Center
Wilmington, North Carolina, United States
- Lynette McFayden · ContactLynette.McFayden@novanthealth.org
- Ibardo Zambrano, MD · Principal investigator
University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Sonobia Garrett · Contactsonobia.garrett@utsouthwestern.edu
- Yair Lotan, MD · Principal investigator
White River Junction Veterans Healthcare System
White River Junction, Vermont, United States
- Laura Jensen, MPH · Contact802-295-9363 ext. 6953Laura.Jensen@va.gov
- Florian R Schroeck, MD, MS · Principal investigator
Study team
Sponsor
Florian Schroeck
Study ID R01CA303719
Principal investigator
Florian R Schroeck, MD, MS
White River Junction Veterans Healthcare System
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.